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Poor recruitment to clinical trials is a well-recognised
and serious problem. Various predictors of poor recruit-
ment have been identified and of course should be
accounted for in trial design. Trial planning however
will need a realistic projection of sample recruitment
that also allows for random variation – yet available
information may be minimal early in the development
of a proposal. Such projections are also required when
estimating power for survival analyses (the yield of
events depends both on numbers and timing of patient
accrual) – for example if using the Stata add-on artsurv.
I show here how minimal information, simple formulae
and some reasonable assumptions can be combined to
estimate both a sensible projection of expected numbers
and a plausible range of variation; in turn this variation
indicates the extent to which achieving the target sample
size may be delayed. Simple calculations also indicate
potential gains from restricting eligibility to better-
performing sites and the relative lack of benefit from
opening better-performing sites first.
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